Introduction Approximately 1-5% of pregnant women experience recurrent pregnancy loss (RPL). Early detection and evaluation of high-risk variables allow for the initiation of recommended treatments while also reducing the likelihood of RPL …
Despite advancements in assisted reproductive technology (ART), recurrent implantation failure (RIF) continues to pose a significant challenge to achieving pregnancy. We included 2,463 retrospective RIF patients with no gynecological and an…
BackgroundSince progesterone alone does not seem to be enough for luteal phase support (LPS), especially in frozen embryo transfer (FET) cycles, so gonadotropin-releasing hormone agonist (GnRH-a) is suggested as an adjuvant therapy in combi…
ObjectiveReproductive medicine needs to find some ways to predict pregnancy outcomes and implantation, which are non-invasive and accurate. Immunologic factors and interleukins are good choices reported in the literature. The purpose of thi…